These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 31854968)

  • 1. Effect of Nanoparticles on the Bulk Shear Viscosity of a Lung Surfactant Fluid.
    Thai LP; Mousseau F; Oikonomou E; Radiom M; Berret JF
    ACS Nano; 2020 Jan; 14(1):466-475. PubMed ID: 31854968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biophysicochemical Interaction of a Clinical Pulmonary Surfactant with Nanoalumina.
    Mousseau F; Le Borgne R; Seyrek E; Berret JF
    Langmuir; 2015 Jul; 31(26):7346-54. PubMed ID: 26075579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of agglomeration and specific lung lining lipid/protein interaction on short-term inhalation toxicity.
    Wohlleben W; Driessen MD; Raesch S; Schaefer UF; Schulze C; Vacano Bv; Vennemann A; Wiemann M; Ruge CA; Platsch H; Mues S; Ossig R; Tomm JM; Schnekenburger J; Kuhlbusch TA; Luch A; Lehr CM; Haase A
    Nanotoxicology; 2016 Sep; 10(7):970-80. PubMed ID: 26984182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heteroaggregation between Al2O3 submicrometer particles and SiO2 nanoparticles: experiment and simulation.
    Cerbelaud M; Videcoq A; Abélard P; Pagnoux C; Rossignol F; Ferrando R
    Langmuir; 2008 Apr; 24(7):3001-8. PubMed ID: 18312002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biophysical inhibition of synthetic vs. naturally-derived pulmonary surfactant preparations by polymeric nanoparticles.
    Beck-Broichsitter M; Ruppert C; Schmehl T; Günther A; Seeger W
    Biochim Biophys Acta; 2014 Jan; 1838(1 Pt B):474-81. PubMed ID: 24184425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteomic and Lipidomic Analysis of Nanoparticle Corona upon Contact with Lung Surfactant Reveals Differences in Protein, but Not Lipid Composition.
    Raesch SS; Tenzer S; Storck W; Rurainski A; Selzer D; Ruge CA; Perez-Gil J; Schaefer UF; Lehr CM
    ACS Nano; 2015 Dec; 9(12):11872-85. PubMed ID: 26575243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Supported pulmonary surfactant bilayers on silica nanoparticles: formulation, stability and impact on lung epithelial cells.
    Mousseau F; Puisney C; Mornet S; Borgne RL; Vacher A; Airiau M; Baeza-Squiban A; Berret JF
    Nanoscale; 2017 Oct; 9(39):14967-14978. PubMed ID: 28953277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of surface charge in the interaction of nanoparticles with model pulmonary surfactants.
    Mousseau F; Berret JF
    Soft Matter; 2018 Jul; 14(28):5764-5774. PubMed ID: 29989135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanoparticles in the lung and their protein corona: the few proteins that count.
    Whitwell H; Mackay RM; Elgy C; Morgan C; Griffiths M; Clark H; Skipp P; Madsen J
    Nanotoxicology; 2016 Nov; 10(9):1385-94. PubMed ID: 27465202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ultrahigh magnetically responsive microplatelets with tunable fluorescence emission.
    Libanori R; Reusch FB; Erb RM; Studart AR
    Langmuir; 2013 Nov; 29(47):14674-80. PubMed ID: 24175712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. On the rheology of pulmonary surfactant: Effects of concentration and consequences for the surfactant replacement therapy.
    Thai LPA; Mousseau F; Oikonomou EK; Berret JF
    Colloids Surf B Biointerfaces; 2019 Jun; 178():337-345. PubMed ID: 30897431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phosphonate coating of SiO
    Großgarten M; Holzlechner M; Vennemann A; Balbekova A; Wieland K; Sperling M; Lendl B; Marchetti-Deschmann M; Karst U; Wiemann M
    Part Fibre Toxicol; 2018 Jul; 15(1):31. PubMed ID: 30012173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of contact angle, zeta potential and particles size on the in vitro studies of Al2O3 and SiO2 nanoparticles.
    Karunakaran G; Suriyaprabha R; Rajendran V; Kannan N
    IET Nanobiotechnol; 2015 Feb; 9(1):27-34. PubMed ID: 25650323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-resolution investigation of nanoparticle interaction with a model pulmonary surfactant monolayer.
    Sachan AK; Harishchandra RK; Bantz C; Maskos M; Reichelt R; Galla HJ
    ACS Nano; 2012 Feb; 6(2):1677-87. PubMed ID: 22288983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interfacial molecular imprinting of Stöber particle surfaces: a simple approach to targeted saccharide adsorption.
    Joshi S; Rao A; Lehmler HJ; Knutson BL; Rankin SE
    J Colloid Interface Sci; 2014 Aug; 428():101-10. PubMed ID: 24910041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction of metal oxide nanoparticles with lung surfactant protein A.
    Schulze C; Schaefer UF; Ruge CA; Wohlleben W; Lehr CM
    Eur J Pharm Biopharm; 2011 Apr; 77(3):376-83. PubMed ID: 21056657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dialysis process for the removal of surfactants to form colloidal mesoporous silica nanoparticles.
    Urata C; Aoyama Y; Tonegawa A; Yamauchi Y; Kuroda K
    Chem Commun (Camb); 2009 Sep; (34):5094-6. PubMed ID: 20448957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lung surfactants and different contributions to thin film stability.
    Hermans E; Bhamla MS; Kao P; Fuller GG; Vermant J
    Soft Matter; 2015 Nov; 11(41):8048-57. PubMed ID: 26307946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alteration of biophysical activity of pulmonary surfactant by aluminosilicate nanoparticles.
    Kondej D; Sosnowski TR
    Inhal Toxicol; 2013 Feb; 25(2):77-83. PubMed ID: 23363039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concentration-dependent, temperature-dependent non-Newtonian viscosity of lung surfactant dispersions.
    King DM; Wang Z; Kendig JW; Palmer HJ; Holm BA; Notter RH
    Chem Phys Lipids; 2001 Jul; 112(1):11-9. PubMed ID: 11518568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.